This rare condition causes a decrease in hepatic blood flow
Serious side effects are less common but may include pancreatitis, gallbladder problems, kidney problems related to dehydration, severe stomach problems, allergic reactions, low blood sugar in people with type 2 diabetes, vision changes, and a possible risk of thyroid tumors
Afterward, the body shifts to burning fat, resulting in slower weight loss
If approved, it would represent yet another step forward in the GLP-1 receptor agonist family
Considering the pleiotropic beneficial actions, excellent safety and tolerability profile, ALCAR has been employed in clinical settings related to neurological disorders [26, 28, 29]
Frequently Asked Questions Laboratory Use What is Retatrutide GLP3-R